Finanzwire Finanzwire
Basculer en Français
11026 Companies
241675 Keywords
170144 Articles
130116 Press releases
Headlines Articles Press releases Lobe Sciences Ltd. Remove
  1. Home
  2. Companies
  3. Lobe Sciences Ltd.
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 04/14/2025 at 13:05, 1 year 5 months ago

    Lobe Sciences Initiates Private Placement for Drug Development

    Private Placement Clinical Trials Lobe Sciences Conjugated Psilocin Cynaptec Pharmaceuticals
  • PRESS RELEASE

    published on 04/14/2025 at 13:00, 1 year 5 months ago

    Lobe Sciences Ltd. Announces Private Placement to Support Drug Development of Novel Conjugated Psilocin(TM)

    Lobe Sciences announces US$6M private placement for Cynaptec to fund Conjugated Psilocin development. Option for additional US$20M included. Company focuses on lipid tech for orphan diseases
    Private Placement Lobe Sciences Lipid Technology Conjugated Psilocin Cynaptec
    Logo of Lobe Sciences Ltd.
  • BRIEF

    published on 04/05/2025 at 05:55, 1 year 5 months ago

    Lobe Sciences Provides Corporate Update on Recent Transactions

    Clinical Trials Convertible Notes FDA Feedback Lobe Sciences Psilocin Mucate
  • PRESS RELEASE

    published on 04/05/2025 at 05:50, 1 year 5 months ago

    Lobe Sciences Provides Corporate Update

    Lobe Sciences provides corporate update on recent transactions and business progress including patents and clinical study results. Focus on lipid technology solutions for medical needs
    Corporate Update Recent Transactions Lobe Sciences Lipid Technology Medical Needs
    Logo of Lobe Sciences Ltd.
Previous page
1 ... 7 8
Accesswire
  • Published on 09/19/2026 at 00:55, 16 hours 3 minutes ago

    Gossan Resources Announces Changes to Board and Management

  • Published on 09/18/2026 at 23:50, 17 hours 8 minutes ago

    Mako Mining Announces Equity Incentive Grants

  • Published on 09/18/2026 at 22:00, 18 hours 58 minutes ago

    Silver Tiger Announces Results of Annual and Special Meeting

  • Published on 09/18/2026 at 20:35, 20 hours 23 minutes ago

    Only 11% of Marketers Expect Google Search to Be Their Customers' Main Starting Point in Two Years

  • Published on 09/18/2026 at 14:30, 1 day 2 hours ago

    AIAI Holdings to Obtain a Controlling Position in Messier 42 Marketing Agreement

View all ACCESSWIRE
EQS Group
  • Published on 09/19/2026 at 16:40, 18 minutes ago

    2026 Cross-Strait (Kunshan) Mid-Autumn Lantern Festival Opens

  • Published on 09/19/2026 at 13:15, 3 hours 43 minutes ago

    Eurobattery Minerals AB has received information regarding court judgment and criminal suspicion concerning the CEO

  • Published on 09/19/2026 at 07:30, 9 hours 28 minutes ago

    Hong Kong sets out initiatives to secure long-term development of pillar industries

  • Published on 09/18/2026 at 18:45, 22 hours 13 minutes ago

    Holding(s) in Company

  • Published on 09/18/2026 at 18:44, 22 hours 14 minutes ago

    EQS-Adhoc: Enapter AG announces preliminary, unaudited figures for the first half of 2026 and restructures its US sales operations – one-off expense of EUR 17 million

View all EQS
Les Echos
  • Published on 09/18/2026 at 18:34, 22 hours 24 minutes ago

    Disclosure of transactions in own shares from September 14 to September 18, 2026

  • Published on 09/18/2026 at 17:45, 23 hours 13 minutes ago

    Press Release_Carrefour Bond_September 2026

  • Published on 09/18/2026 at 17:45, 23 hours 13 minutes ago

    Share buyback for cancellation

  • Published on 09/17/2026 at 17:40, 1 day 23 hours ago

    Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany

  • Published on 09/16/2026 at 20:46, 2 days 20 hours ago

    LNA SANTE : 2026 First Half Results

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy